Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective

<p> Innovative and enduring solutions to the myriad of complex social and environmental challenges facing the world today require the shared resources and combined talents of government, nonprofit and for-profit sectors. Interactions between these sectors are called cross sector partnerships (...

Full description

Bibliographic Details
Main Author: Miller, Monica
Language:EN
Published: Pepperdine University 2019
Subjects:
Online Access:http://pqdtopen.proquest.com/#viewpdf?dispub=13811665
id ndltd-PROQUEST-oai-pqdtoai.proquest.com-13811665
record_format oai_dc
spelling ndltd-PROQUEST-oai-pqdtoai.proquest.com-138116652019-04-11T15:45:36Z Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective Miller, Monica Management|Organizational behavior <p> Innovative and enduring solutions to the myriad of complex social and environmental challenges facing the world today require the shared resources and combined talents of government, nonprofit and for-profit sectors. Interactions between these sectors are called cross sector partnerships (CSPs). As an example of CSPs, nonprofit patient advocacy organizations (PAOs) are increasingly entering relationships and collaborations with for-profit pharmaceutical companies (FPPCs). Using a phenomenological approach, this study sought to contribute to the body of knowledge on PAO/FPPC partnerships, as well as the broader CSP phenomenon, by exploring how leaders in the field of PAO/FPPC alliances experience collaboration with one another. Three research questions were used as the basis of semi-structured interviews with 11 patient advocacy leaders. Five of the participants were nonprofit leaders (NPLs) and six were for-profit leaders (FPLs). Results from this study include several important new contributions that add to the body of knowledge related to PAO/FPPC cross sector alliances. First, the data describe disparities in decision-making authority between the NPLs and FPLs and the data illustrate the complex, variable and challenging decision-making context that exists in PAO/FPPC partnerships. Second, these results confirm that strategic analysis skills, marketing skills and facilitation skills are important leadership competencies that impact productive PAO/FPPC partnerships. Finally, this research describes similarities and differences in leadership competencies that are important to NPLs and FPLs. This study is significant because an increased understanding of collaborations between patient advocacy organizations and drug development companies may allow for more positive and beneficial future collaborations. In addition, this research provides insight into the general phenomena of cross sector alliances, which may prove beneficial to a wide range of social challenges.</p><p> Pepperdine University 2019-04-06 00:00:00.0 thesis http://pqdtopen.proquest.com/#viewpdf?dispub=13811665 EN
collection NDLTD
language EN
sources NDLTD
topic Management|Organizational behavior
spellingShingle Management|Organizational behavior
Miller, Monica
Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
description <p> Innovative and enduring solutions to the myriad of complex social and environmental challenges facing the world today require the shared resources and combined talents of government, nonprofit and for-profit sectors. Interactions between these sectors are called cross sector partnerships (CSPs). As an example of CSPs, nonprofit patient advocacy organizations (PAOs) are increasingly entering relationships and collaborations with for-profit pharmaceutical companies (FPPCs). Using a phenomenological approach, this study sought to contribute to the body of knowledge on PAO/FPPC partnerships, as well as the broader CSP phenomenon, by exploring how leaders in the field of PAO/FPPC alliances experience collaboration with one another. Three research questions were used as the basis of semi-structured interviews with 11 patient advocacy leaders. Five of the participants were nonprofit leaders (NPLs) and six were for-profit leaders (FPLs). Results from this study include several important new contributions that add to the body of knowledge related to PAO/FPPC cross sector alliances. First, the data describe disparities in decision-making authority between the NPLs and FPLs and the data illustrate the complex, variable and challenging decision-making context that exists in PAO/FPPC partnerships. Second, these results confirm that strategic analysis skills, marketing skills and facilitation skills are important leadership competencies that impact productive PAO/FPPC partnerships. Finally, this research describes similarities and differences in leadership competencies that are important to NPLs and FPLs. This study is significant because an increased understanding of collaborations between patient advocacy organizations and drug development companies may allow for more positive and beneficial future collaborations. In addition, this research provides insight into the general phenomena of cross sector alliances, which may prove beneficial to a wide range of social challenges.</p><p>
author Miller, Monica
author_facet Miller, Monica
author_sort Miller, Monica
title Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
title_short Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
title_full Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
title_fullStr Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
title_full_unstemmed Leadership Challenges for Patient Advocates| A Cross Sector Alliance Perspective
title_sort leadership challenges for patient advocates| a cross sector alliance perspective
publisher Pepperdine University
publishDate 2019
url http://pqdtopen.proquest.com/#viewpdf?dispub=13811665
work_keys_str_mv AT millermonica leadershipchallengesforpatientadvocatesacrosssectorallianceperspective
_version_ 1719017510969278464